Search

Sartorius Stedim Biotech.

Open

SectorFinance

205 -0.87

Overview

Share price change

24h

Current

Min

201.8

Max

207.6

Key metrics

By Trading Economics

Income

4.9M

93M

Sales

4.2M

766M

P/E

Sector Avg

66.977

20.954

EPS

1.25

Dividend yield

0.35

Profit margin

12.146

Employees

10,477

EBITDA

9.2M

240M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+16.28% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.35%

4.63%

Next Earnings

22 Oct 2026

Market Stats

By TradingEconomics

Market Cap

2.1B

20B

Previous open

205.87

Previous close

205

News Sentiment

By Acuity

41%

59%

95 / 438 Finance

Sartorius Stedim Biotech. Chart

Past performance is not a reliable indicator of future results.

Related News

22 Sept 2026, 23:55 UTC

News

Roivant Sciences Ltd is higher in after-market trading following positive Phase 2 trial results for mosliciguat, showing significant improvements in pulmonary hypertension patients.

22 Sept 2026, 23:51 UTC

News

Itron Inc's stock is declining in after-market trading, despite the launch of its Riva IEC Grid Edge Portfolio in the Asia Pacific region.

22 Sept 2026, 23:50 UTC

News

Coeur Mining plans a record $158 million exploration investment for 2026, more than double 2025's budget, as shares rise in after-market trading.

22 Sept 2026, 23:41 UTC

Social Media
Event
News

NN, Inc. raised its 2026 net sales guidance to $470M-$490M and adjusted EBITDA to $58M-$68M, leading to a sharp after-market hours increase.

22 Sept 2026, 23:35 UTC

News

Tencent Music Entertainment Group's shares rose in after-market trading, maintaining a strong performance above the 20-day moving average since Tuesday's close.

22 Sept 2026, 23:35 UTC

News

Quest Diagnostics will release third-quarter results on October 22, 2026, and is modestly higher in after-market trading since Tuesday's close.

22 Sept 2026, 23:31 UTC

Correlated Moves
News

Dynex Capital Inc announced a public offering of 4.8M shares of preferred stock, expected to raise $120 million, with shares trading higher in after-market hours.

22 Sept 2026, 23:31 UTC

News

Peloton Interactive Inc. plans to launch the "Tread Flex" treadmill as part of its turnaround strategy, contributing to modest gains in after-market trading.

22 Sept 2026, 23:25 UTC

News

Domo Inc completes asset sale to Progress Software, rebranding as Huckleberry.ai, and is now debt-free with $221 million in cash, shares advancing in after-market trading.

22 Sept 2026, 23:21 UTC

Social Media
News

Meta's Muse AI app tops U.S. App Store, leading to after-market gains as analysts raise price targets to $820 and $796 amid strong user engagement.

22 Sept 2026, 23:10 UTC

News

Shares declined in after-market trading; implied volatility at yearly low.

22 Sept 2026, 23:10 UTC

News

General Electric Co is trading slightly higher in after-market hours, supported by a $170 billion commercial services backlog and strong pricing power.

22 Sept 2026, 23:10 UTC

News

RTX Corp received a $105.6 million contract modification from the U.S. Department of War for missile parts, with work expected to complete by August 31, 2027.

22 Sept 2026, 23:10 UTC

News

V2X Inc received a $231.8 million contract modification from the U.S. Air Force, raising total contract value to $594.2 million, boosting stock in after-market trading.

22 Sept 2026, 23:06 UTC

News

Home Depot announced a partnership with TP-Link to offer exclusive Tapo smart home security camera bundles in 500 stores and online, with shares roughly flat in after-market trading.

22 Sept 2026, 23:06 UTC

News

Microsoft will consider shareholder proposals at its annual meetings, following an agreement with activist Paul Chesser, and is trading higher in after-market hours.

22 Sept 2026, 23:06 UTC

News

General Motors Co is trading lower in after-market hours, having retraced from earlier gains and falling below its 20-day moving average.

22 Sept 2026, 23:06 UTC

News

Verizon Communications Inc. is seeing a modest increase in after-market trading, bolstered by the launch of a new 5G handset and expanded 6G research partnerships.

22 Sept 2026, 23:06 UTC

News

XRP has gained traction, supported by positive trading posts and recent performance in liquidity pools, despite pulling back from earlier session highs.

22 Sept 2026, 23:06 UTC

News

Eli Lilly's stock is higher in after-market trading as the company begins construction on a $6.5 billion facility for its oral GLP-1 drug, Foundayo.

22 Sept 2026, 23:05 UTC

News

Star Bulk Carriers is trading higher in after-market hours, rebounding from a dip, as Alexandros Pappas purchased $2.1 million in stock at $28.27 per share.

22 Sept 2026, 23:01 UTC

News

Intercontinental Exchange Inc. has launched a private credit reference data service for institutional clients, contributing to its gains in after-market trading.

22 Sept 2026, 23:01 UTC

News
Social Media

Brighthouse Financial's shares rose in after-market trading as Sixth Street reiterated its interest in acquiring the company amid regulatory delays with another buyer.

22 Sept 2026, 23:01 UTC

Social Media
News

CME Group plans to introduce Bitcoin Cash and Uniswap futures on October 19, pending regulatory approval, as its stock moves higher in after-market trading.

22 Sept 2026, 23:01 UTC

News

CF Industries Holdings Inc is advancing in after-market trading, recovering from recent declines amid concerns over a potential potash supply deal with Belarus.

22 Sept 2026, 23:01 UTC

Event
News

Worthington Enterprises reported Q1 fiscal 2027 net sales of $343.9 million and EPS of $0.87, exceeding expectations, driving the stock sharply higher in after-market trading.

22 Sept 2026, 23:01 UTC

Social Media
News

Sharp decline in revenues and net income leads to after-hours drop.

22 Sept 2026, 23:01 UTC

News

General Mills Inc's adjusted diluted EPS is projected between $3 and $3.20, with shares moving modestly higher in after-market trading.

22 Sept 2026, 23:01 UTC

News

Credit Acceptance Corporation appointed Shannon Wilson as Chief Human Resources Officer, effective September 28, 2026, contributing to an upward move in after-market trading.

22 Sept 2026, 23:01 UTC

News

Williams-Sonoma Inc's market capitalization is $27.41 billion, with the stock showing a notable increase in after-market trading, continuing a five-session positive trend.

Peer Comparison

Price change

Sartorius Stedim Biotech. Forecast

Price Target

By TipRanks

16.28% upside

12 Months Forecast

Average 240 EUR  16.28%

High 260 EUR

Low 210 EUR

Based on 5 Wall Street analysts offering 12 month price targets forSartorius Stedim Biotech. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Sentiment

By Acuity

95 / 438 Finance

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.